BMRN Biomarin Pharmaceutical Inc. - Registered Shares
5,040
$77.56
$0.59
(0.77%)
| Watchers | 5,040 |
| 52-Wk Low | $76.02 |
| 52-Wk High | $99.56 |
| Market Cap | $15.27B |
| Volume | 3.43M |
| 52-Wk High | $99.56 |
| 52-Wk Low | $76.02 |
Analyst Ratings For Biomarin PharmaceuticalBenzinga • 3 days ago
Latest Ratings for BMRN
DateFirmActionFromTo Feb 2022Piper SandlerMaintainsOverweight Nov 2021Credit SuisseMaintainsOutperform Nov 2021Morgan StanleyMaintainsEqual-Weight
View More Analyst...
Share to Feed
BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV BioMarin to Present at the BofA Securities 2024 Health Care...
New Data for BioMarin's VOXZOGO (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting New Data for BioMarin's VOXZOGO...
Latest Ratings for BMRN
DateFirmActionFromTo Feb 2022Piper SandlerMaintainsOverweight Nov 2021Credit SuisseMaintainsOutperform Nov 2021Morgan StanleyMaintainsEqual-Weight
View More Analyst...
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET BioMarin to Host First Quarter 2024 Financial Results Conference Call and...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) EVP George Eric Davis sold 24,602 shares of the stock in a transaction dated Thursday, March 28th. The shares were sold at an average...
read more...
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
It has been about a month since the last earnings report for Beam Therapeutics Inc. (BEAM). Shares have lost about 22.1% in that time frame, underperforming the S&P 500.Will the recent negative trend...
Atara Biotherapeutics (ATRA) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $0.72 per share a year ago. These...